337 related articles for article (PubMed ID: 17461888)
21. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
Beydoun A; D'Souza J; Hebert D; Doty P
Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666
[TBL] [Abstract][Full Text] [Related]
22. Antinociceptive effects of lacosamide on spinal neuronal and behavioural measures of pain in a rat model of osteoarthritis.
Rahman W; Dickenson AH
Arthritis Res Ther; 2014 Dec; 16(6):509. PubMed ID: 25533381
[TBL] [Abstract][Full Text] [Related]
23. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
24. Seeking a mechanism of action for the novel anticonvulsant lacosamide.
Errington AC; Coyne L; Stöhr T; Selve N; Lees G
Neuropharmacology; 2006 Jun; 50(8):1016-29. PubMed ID: 16620882
[TBL] [Abstract][Full Text] [Related]
25. Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study.
Casciato S; Quarato PP; Gialluisi A; D'Aniello A; Mascia A; Grammaldo LG; Di Gennaro G
Epilepsy Behav; 2021 Sep; 122():108128. PubMed ID: 34229159
[TBL] [Abstract][Full Text] [Related]
26. Current understanding of the mechanism of action of the antiepileptic drug lacosamide.
Rogawski MA; Tofighy A; White HS; Matagne A; Wolff C
Epilepsy Res; 2015 Feb; 110():189-205. PubMed ID: 25616473
[TBL] [Abstract][Full Text] [Related]
27. Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice.
Shandra A; Shandra P; Kaschenko O; Matagne A; Stöhr T
Epilepsia; 2013 Jul; 54(7):1167-75. PubMed ID: 23750855
[TBL] [Abstract][Full Text] [Related]
28. Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus.
Wang X; Yu Y; Ma R; Shao N; Meng H
Neuroreport; 2018 Nov; 29(16):1384-1390. PubMed ID: 30169428
[TBL] [Abstract][Full Text] [Related]
29. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide.
Wilson SM; Khanna R
Mol Neurobiol; 2015 Apr; 51(2):599-609. PubMed ID: 24944082
[TBL] [Abstract][Full Text] [Related]
30. Advances in epilepsy treatment: lacosamide pharmacokinetic profile.
Cawello W; Stockis A; Andreas JO; Dimova S
Ann N Y Acad Sci; 2014 Nov; 1329():18-32. PubMed ID: 25167889
[TBL] [Abstract][Full Text] [Related]
31. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
[TBL] [Abstract][Full Text] [Related]
32. Clinical management of elderly patients with epilepsy; the use of lacosamide in a single center setting.
Rainesalo S; Mäkinen J; Raitanen J; Peltola J
Epilepsy Behav; 2017 Oct; 75():86-89. PubMed ID: 28834781
[TBL] [Abstract][Full Text] [Related]
33. Lacosamide for the treatment of partial-onset seizures.
Biton V
Expert Rev Neurother; 2012 Jun; 12(6):645-55. PubMed ID: 22650166
[TBL] [Abstract][Full Text] [Related]
34. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
35. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
[TBL] [Abstract][Full Text] [Related]
36. Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.
Becerra JL; Ojeda J; Corredera E; Ruiz Giménez J
CNS Drugs; 2011 Dec; 25 Suppl 1():3-16. PubMed ID: 22141347
[TBL] [Abstract][Full Text] [Related]
37. Lacosamide for the treatment of diabetic neuropathic pain.
Biton V
Expert Rev Neurother; 2008 Nov; 8(11):1649-60. PubMed ID: 18986235
[TBL] [Abstract][Full Text] [Related]
38. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
[TBL] [Abstract][Full Text] [Related]
39. Lacosamide: in partial-onset seizures.
Cross SA; Curran MP
Drugs; 2009; 69(4):449-59. PubMed ID: 19323588
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]